Drug Shortage Report for TEVA-LATANOPROST
Report ID | 218963 |
Drug Identification Number | 02254786 |
Brand name | TEVA-LATANOPROST |
Common or Proper name | LATANOPROST EYE DROP SOL'N |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | LATANOPROST |
Strength(s) | 50MCG |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 0.005% |
ATC code | S01EE |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-02-07 |
Estimated end date | 2024-12-20 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-03-21 | French | Compare |
v7 | 2024-03-21 | English | Compare |
v6 | 2024-02-29 | French | Compare |
v5 | 2024-02-29 | English | Compare |
v4 | 2024-02-22 | French | Compare |
v3 | 2024-02-22 | English | Compare |
v2 | 2024-02-08 | French | Compare |
v1 | 2024-02-08 | English | Compare |
Showing 1 to 8 of 8